Recent News

• 03.05.2025 - Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
• 03.05.2025 - Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
• 02.27.2025 - Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
• 02.27.2025 - Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
• 02.11.2025 - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
• 02.11.2025 - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
• 02.10.2025 - Mustang Bio Announces Closing of $8 Million Public Offering

Recent Filings

• 03.05.2025 - 8-K Current report
• 03.05.2025 - EX-99.1 EX-99.1
• 03.03.2025 - DEF 14C Other definitive information statements
• 02.27.2025 - 8-K Current report
• 02.27.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.21.2025 - PRE 14C Other preliminary information statements
• 02.21.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.13.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.13.2025 - 8-K Current report